Kazuaki Taguchi Selected Research

Kazuaki Taguchi Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 01/2018
10	Hemorrhage 01/2021 - 04/2011
9	Hemorrhagic Shock 11/2020 - 06/2009
6	Infections 03/2022 - 01/2020
5	Chronic Renal Insufficiency 01/2022 - 12/2012
5	Fibrosis (Cirrhosis) 01/2022 - 02/2011
5	Thrombocytopenia (Thrombopenia) 01/2019 - 01/2013
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2019
4	Wounds and Injuries (Trauma) 01/2020 - 02/2015
4	Inflammation (Inflammations) 01/2016 - 09/2011
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2018
3	Hypoxia (Hypoxemia) 01/2022 - 10/2015
3	Poisoning 01/2022 - 10/2021
3	Hypoalbuminemia 06/2021 - 12/2010
3	Renal Insufficiency (Renal Failure) 01/2013 - 07/2007
2	Meningitis 08/2022 - 09/2021
2	Bacterial Meningitis 08/2022 - 09/2021
2	Rhabdomyolysis 01/2022 - 01/2020
2	Invasive Candidiasis 11/2021 - 11/2020
2	Clostridium Infections 10/2021 - 11/2018
2	Candidemia 07/2021 - 11/2020
2	Chronic Hepatitis B 01/2020 - 06/2018
2	Pain (Aches) 05/2019 - 12/2012
2	Hepatitis 11/2018 - 02/2015
2	Pancreatitis 11/2018 - 01/2016
2	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2015
2	Hypertension (High Blood Pressure) 01/2018 - 12/2009
2	Lung Injury 01/2016 - 09/2011
2	Fetal Hypoxia 10/2015 - 10/2012
2	Chronic Kidney Failure (Chronic Renal Failure) 12/2012 - 07/2007
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2011 - 11/2010
1	Bacteremia 03/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Pneumonia (Pneumonitis) 01/2022

Drug/Important Bio-Agent (IBA)

14	Pharmaceutical PreparationsIBA 12/2021 - 10/2013
12	Carbon MonoxideIBA 01/2022 - 01/2013
12	Hemoglobins (Hemoglobin)IBA 12/2021 - 06/2009
8	Liposomes (Liposome)IBA 12/2021 - 03/2011
7	Proteins (Proteins, Gene)FDA Link 08/2022 - 09/2011
7	AlbuminsIBA 01/2020 - 12/2010
6	Oxygen (Dioxygen)IBA 01/2020 - 06/2009
6	Human Serum Albumin FDA LinkGeneric 11/2019 - 12/2010
5	Therapeutic UsesIBA 01/2022 - 08/2014
5	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 11/2020 - 01/2013
5	AntioxidantsIBA 01/2018 - 01/2015
4	Vancomycin FDA LinkGeneric 03/2022 - 11/2018
4	Daptomycin FDA Link 03/2022 - 01/2020
4	EchinocandinsIBA 01/2022 - 11/2020
4	CytokinesIBA 01/2016 - 08/2014
3	Anti-Bacterial Agents (Antibiotics)IBA 08/2022 - 01/2020
3	AntidotesIBA 01/2022 - 10/2021
3	MethemoglobinIBA 01/2022 - 10/2021
3	Cyanides (Isocyanides)IBA 01/2022 - 10/2021
3	Linezolid (Zyvox)FDA Link 01/2022 - 01/2013
3	NucleosidesIBA 05/2021 - 06/2018
3	4'-cyano-2'-deoxyguanosineIBA 05/2021 - 06/2018
3	Fibrinogen (Factor I)FDA Link 09/2015 - 08/2013
3	Immunoglobulin M (IgM)IBA 09/2015 - 03/2011
3	Adenosine Diphosphate (ADP)IBA 09/2015 - 08/2013
3	Biological ProductsIBA 08/2015 - 01/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2015 - 07/2007
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 08/2022 - 12/2019
2	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2022 - 10/2021
2	SuspensionsIBA 12/2021 - 01/2016
2	beta-Lactamases (beta-Lactamase)IBA 11/2021 - 01/2021
2	A-factor (Streptomyces)IBA 10/2021 - 12/2019
2	Metronidazole (Metric)FDA LinkGeneric 10/2021 - 11/2018
2	PolyenesIBA 11/2020 - 11/2020
2	CytochromesIBA 10/2020 - 01/2013
2	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2018
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2019
2	SaltsIBA 12/2019 - 01/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 05/2019
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 01/2018
2	BenzbromaroneIBA 01/2018 - 01/2015
2	Heme (Haem)IBA 10/2015 - 07/2014
2	Acetaminophen (Paracetamol)FDA LinkGeneric 02/2015 - 12/2012
2	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2011 - 11/2010
1	Ceftazidime (Fortum)FDA LinkGeneric 08/2022
1	Adenosine Monophosphate (AMP)IBA 03/2022
1	tedizolidIBA 01/2022
1	Gemcitabine FDA Link 01/2022
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2022
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2022
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	NivolumabIBA 01/2022
1	Ethambutol (Myambutol)FDA LinkGeneric 01/2022
1	salicylhydroxamic acid (SHAM)IBA 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	CytidineIBA 01/2022
1	2-methylcyclopentadienyl manganese tricarbonyl (MMT)IBA 01/2022

Therapy/Procedure

9	Resuscitation 11/2020 - 06/2009
8	Therapeutics 01/2022 - 10/2012
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2020
2	Oral Administration 05/2019 - 01/2018
2	Erythrocyte Transfusion 11/2015 - 01/2013
2	Injections 09/2015 - 03/2011
2	Ligation 10/2012 - 04/2011
1	Lung Transplantation 01/2022